The Motley Fool

Rhys Brock

Rhys Brock has been a Motley Fool contributor since late 2017. Originally a literature graduate with a passion for writing, his travels took him to the United Kingdom and the Cayman Islands, where he made ends meet working administrative jobs in banking and hedge fund administration. This exposure to the global finance industry uncovered a fascination with international markets and investing. Now back in Australia, and having passed all three levels of the CFA Program, Rhys is keen to share his passion for investing with Motley Fool readers.

The EML Payments share price skyrocketed 200% in 2019. Could 2020 be even better?

Despite its shares surging over 200% higher in 2019, I think the best may still be yet to come for payments provider EML Payments... More »

3 ASX companies to watch in 2020

These 3 ASX companies that have already laid solid foundations for future growth – so much so that 2020 might even end up being... More »

3 ASX growth shares that could become tomorrow’s blue-chips

If you’ve decided 2020 will be the year you finally start building your share portfolio, here are my three picks for ASX growth stocks... More »

The a2 Milk share price has rebounded 30% since November, but is it a buy?

The A2 Milk Company Ltd (ASX: A2M) share price has rebounded strongly since early November, but I think the company has a little way... More »

Is the Jumbo Interactive share price a buy?

The share price of online lottery company Jumbo Interactive Limited (ASX:JIN) has plunged over 45% since late October. Here’s why I think it could... More »

Why you should add this ASX healthcare company to your Christmas wish list

The share price of healthcare company ResMed Inc (ASX: RMD) recently raced to an all-time high of $22.91. Here’s why I still think it... More »

Are Zip Co shares still a buy?

Shares in Zip Co Limited (ASX:Z1P) have dropped over 40% since their mid-October high of $5.86. Is now the time to buy? More »

Why the Medical Developments share price is up 50% since October

Shares in healthcare company Medical Developments International Limited (ASX:MVP) are up over 50% since October after a string of positive announcements concerning its trauma... More »

Should you invest in Bubs Australia shares?

Despite some major announcements this month, the Bubs Australia Ltd (ASX:BUB) share price has gone nowhere. More »

5 ASX growth shares I’d buy today with $10,000

These are my tips for the top ASX growth stocks that I think will outperform the market over the next two to three years. More »

The Nearmap share price is up 15% in a week. Is it a buy?

After a disappointing past few months, shares in aerial imaging company Nearmap Ltd (ASX:NEA) are up 15% in the last week. Is this the... More »

LiveTiles is down 10% this year. Here’s why I still think it’s a buy

Despite strong financial results and a strategic alliance with international tech juggernaut Microsoft, the share price of LiveTiles Limited (ASX: LVT) has been trending... More »

Should you invest in Hub24?

After surging to an all-time high in May, the share price of wealth management firm HUB24 Limited (ASX:HUB) has come off the boil recently. More »

The share price is up 40% this year. Is it a buy?

The Ltd (ASX: CAR) share price has stormed over 40% higher so far this year – but here’s why the company’s stock may... More »